Active Surveillance: Living Well Long-Term
At a Glance
Regular, individualized follow-up helps people with primary lateral sclerosis track movement, reassess the diagnosis, and address breathing, swallowing, fatigue, falls, anxiety, and changing support needs early. Pacing and long-term planning can help protect quality of life.
Living with Primary Lateral Sclerosis (PLS) is a long-term journey. Because the disease often spans decades, your medical care shifts from “finding an answer” to “maintaining your life.” Long-term management is about active surveillance—watching for small changes and adjusting your support system before those changes become problems [1][2].
The Surveillance Schedule
Ongoing follow-up with your multidisciplinary clinic is an important option to discuss. A schedule of every six months is common, but the appropriate interval depends on diagnostic uncertainty, symptom burden, access, and new swallowing, breathing, falls, or medication issues [1]. These check-ups allow your team to:
- Track Progression: Doctors use functional scales to measure how well you are performing daily tasks. Many centers use the ALSFRS-R, timed mobility tests, or the PLS Functional Rating Scale (PLSFRS) [3][4].
- Re-evaluate the Diagnosis: Especially during the first four years, your neurologist will check for any new signs of lower motor neuron involvement. Reaching the four-year mark improves diagnostic confidence, but new or atypically rapid findings still require reassessment after the four-year point [5][6].
- Adjust Equipment: Your physical and occupational therapists will ensure your mobility aids—like braces, canes, or walkers—are still providing the right level of safety and balance [7][8].
Managing “Progression Anxiety”
It is completely normal to feel a high level of anxiety as you wait to reach the four-year diagnostic mark. This “progression anxiety”—the fear that your symptoms might suddenly speed up or turn into ALS—is a documented psychological burden for many PLS patients [9][10].
Validating these feelings is a key part of your care. Many patients find that Cognitive-Behavioral Therapy (CBT) or support groups specifically for rare motor neuron diseases help manage the uncertainty [1]. A subset of patients may experience cognitive or behavioral changes, which should be assessed rather than assumed to be disease-related, and deserve treatment in their own right [10][11].
Breathing and Nutrition: The “Safety Check”
In ALS, breathing and swallowing issues often appear early and move fast. In PLS, these issues are statistically less frequent or slower on average, but they can still occur and become medically serious [12][13].
- Respiratory Checks: Routine respiratory testing is reasonable, but the choice of FVC, supine testing, or overnight oximetry should be individualized [14]. You do not need to wait for a scheduled visit: new orthopnea (breathlessness lying flat), morning headaches, daytime somnolence, weak cough, or recurrent infections warrant earlier assessment [15][13].
- Nutritional Surveillance: Your team will monitor your weight and ask about swallowing difficulty [1][16]. Feeding tubes (PEG), respiratory support, and palliative-care discussions should be framed as individualized options to maintain your health rather than predictions of imminent decline [13][17].
Energy Management and “Pacing”
Because your muscles are constantly fighting stiffness, you may experience significant fatigue. Pacing—the practice of breaking tasks into smaller pieces and alternating activity with rest—is essential [7].
- Home Adaptations: Simple changes, like adding grab bars in the shower or using a stool while preparing meals, can significantly reduce your daily energy “spend” and prevent falls [18][19].
Planning for the Long Term
Because survival with PLS is often prolonged, you have the opportunity to plan for the long haul [2][16].
- Financial and Career Planning: Early discussions with your employer about workplace accommodations can help you stay in the workforce longer.
- Caregiving: Discussions about who will help you as disability accumulates should happen early, while you are feeling well, to ensure your preferences are documented and respected [1].
By staying consistent with your visits and being proactive about your needs, you can maintain a high quality of life throughout your journey with PLS.
Common questions in this guide
How often should someone with PLS have follow-up visits?
Why does the four-year mark matter in primary lateral sclerosis?
Which breathing symptoms should prompt an earlier PLS assessment?
How can pacing help with PLS fatigue?
How are swallowing and nutrition monitored in PLS?
What can help with anxiety about PLS progression?
Questions For You
Answer a question to get research tailored to you. Your answers are private.
Get notified when new evidence is published on Primary lateral sclerosis.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.What is my current score on our functional rating scale, and how has it changed since our last visit?
- 2.Are my latest breathing test results within the expected range for someone with my level of mobility?
- 3.How should we manage my 'progression anxiety' as we approach the four-year diagnostic mark?
- 4.Is it time for a formal cognitive or behavioral screening to help my family understand any changes they might be seeing?
- 5.What home modifications should we prioritize this year to help me conserve energy?
References
References (19)
- 1
Primary Lateral Sclerosis French National Diagnostic and Care Protocol.
Corcia P, Bernard E, de la Cruz E, et al.
Revue neurologique 2026; (182(6)):555-562 doi:10.1016/j.neurol.2026.04.006.
PMID: 42168009 - 2
Progression and life expectancy in primary lateral sclerosis.
Lester DG, Thompson AG, Talbot K, Turner MR
Journal of neurology, neurosurgery, and psychiatry 2025; (96(10)):1008-1011 doi:10.1136/jnnp-2025-336037.
PMID: 40379483 - 3
Primary lateral sclerosis (PLS) functional rating scale: PLS-specific clinimetric scale.
Mitsumoto H, Chiuzan C, Gilmore M, et al.
Muscle & nerve 2020; (61(2)):163-172 doi:10.1002/mus.26765.
PMID: 31758557 - 4
Measuring disease progression in primary lateral sclerosis.
Gilmore M, Elman L, Babu S, et al.
Amyotrophic lateral sclerosis & frontotemporal degeneration 2020; (21(sup1)):59-66 doi:10.1080/21678421.2020.1837179.
PMID: 33602016 - 5
Diagnostic Revision From Primary Lateral Sclerosis to Amyotrophic Lateral Sclerosis: A Cohort Study.
de Boer EMJ, Willemse SW, Veldink JH, et al.
Neurology 2026; (106(12)):e218055 doi:10.1212/WNL.0000000000218055.
PMID: 42214042 - 6
Primary Lateral Sclerosis: Implications for Diagnostic Criteria From a Natural History Study in the Netherlands.
de Vries BS, de Boer EMJ, Brugman F, et al.
Neurology 2025; (104(11)):e213461 doi:10.1212/WNL.0000000000213461.
PMID: 40388677 - 7
Clinical care and therapeutic trials in PLS.
Floeter MK, Warden D, Lange D, et al.
Amyotrophic lateral sclerosis & frontotemporal degeneration 2020; (21(sup1)):67-73 doi:10.1080/21678421.2020.1837180.
PMID: 33602017 - 8
Evolving diagnostic criteria in primary lateral sclerosis: The clinical and radiological basis of "probable PLS".
Finegan E, Li Hi Shing S, Siah WF, et al.
Journal of the neurological sciences 2020; (417()):117052 doi:10.1016/j.jns.2020.117052.
PMID: 32731060 - 9
Primary lateral sclerosis: a distinct entity or part of the ALS spectrum?
Finegan E, Chipika RH, Shing SLH, et al.
Amyotrophic lateral sclerosis & frontotemporal degeneration 2019; (20(3-4)):133-145 doi:10.1080/21678421.2018.1550518.
PMID: 30654671 - 10
Early Cognitive and Behavioral Changes in Primary Lateral Sclerosis: A Population-Based Study.
Calvo A, Moglia C, Canosa A, et al.
European journal of neurology 2026; (33(8)):e70720 doi:10.1111/ene.70720.
PMID: 42538773 - 11
A neuropsychological and behavioral study of PLS.
de Vries BS, Spreij LA, Rustemeijer LMM, et al.
Amyotrophic lateral sclerosis & frontotemporal degeneration 2019; (20(5-6)):376-384 doi:10.1080/21678421.2019.1620284.
PMID: 31134825 - 12
The NEALS primary lateral sclerosis registry.
Paganoni S, De Marchi F, Chan J, et al.
Amyotrophic lateral sclerosis & frontotemporal degeneration 2020; (21(sup1)):74-81 doi:10.1080/21678421.2020.1804591.
PMID: 32915077 - 13
The Role of Gastrostomy and Noninvasive Ventilation in Primary Lateral Sclerosis.
Oliveira Santos M, Domingues S, Simão S, et al.
Muscle & nerve 2025; (71(3)):450-456 doi:10.1002/mus.28346.
PMID: 39801319 - 14
Respiratory muscle testing in amyotrophic lateral sclerosis: a practical approach.
Sferrazza Papa GF, Pellegrino GM, Shaikh H, et al.
Minerva medica 2018; (109(6 Suppl 1)):11-19 doi:10.23736/S0026-4806.18.05920-7.
PMID: 30642145 - 15
Neurophysiological features of primary lateral sclerosis.
de Carvalho M, Kiernan MC, Pullman SL, et al.
Amyotrophic lateral sclerosis & frontotemporal degeneration 2020; (21(sup1)):11-17 doi:10.1080/21678421.2020.1837174.
PMID: 33602011 - 16
Primary lateral sclerosis: diagnosis and management.
Turner MR, Talbot K
Practical neurology 2020; (20(4)):262-269 doi:10.1136/practneurol-2019-002300.
PMID: 32217663 - 17
Natural History of "Pure" Primary Lateral Sclerosis.
Hassan A, Mittal SO, Hu WT, et al.
Neurology 2021; (96(17)):e2231-e2238 doi:10.1212/WNL.0000000000011771.
PMID: 33637635 - 18
Amyotrophic Lateral Sclerosis: A Review.
Ravits J, Ferrey D, Gundogdu B, et al.
JAMA 2026; (335(22)):1970-1982 doi:10.1001/jama.2026.6385.
PMID: 42113599 - 19
A Case Report on Robot-Aided Gait Training in Primary Lateral Sclerosis Rehabilitation: Rationale, Feasibility and Potential Effectiveness of a Novel Rehabilitation Approach.
Portaro S, Ciatto L, Raciti L, et al.
Innovations in clinical neuroscience 2021; (18(4-6)):15-19.
PMID: 34980978
This page provides educational information about long-term surveillance and self-management in primary lateral sclerosis; it does not replace medical advice. Discuss changes in breathing, swallowing, mobility, mood, or cognition with your care team.